Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa

International Journal of Molecular Medicine

Volumn 17, Issue 2, 2006, Pages 309-317

  Wang, Jing ^a   Hu, Bei ^b   Xu, Minchao ^b   Yan, Qun ^b   Liu, Shuangyou ^b   Zhu, Xuhui ^b   Sun, Ziyong ^b   Reed, Eddie ^c   Ding, Li ^d   Gong, Jianping ^b   Li, Qingdi Q ^c,e   Hu, Junbo ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c WEST VIRGINIA UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e NONE   (United States)

Author keywords

Animal model; Bacteremia; Drug resistance; Imipenem resistance; Mouse; P. aeruginosa; Phage therapy

Indexed keywords

IMIPENEM;

ANIMAL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIOPHAGE; BAGG ALBINO MOUSE; DISEASE MODEL; DRUG EFFECT; ELECTRON MICROSCOPY; FEMALE; GENE THERAPY; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MOUSE; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; TEMPERATURE; ULTRASTRUCTURE; VIROLOGY;

ANIMALS; BACTEREMIA; BACTERIOPHAGES; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENE THERAPY; IMIPENEM; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; PSEUDOMONAS AERUGINOSA; TEMPERATURE;

EID: 33644858928     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.2.309     Document Type: Article

References (22)

1. Cohen ML: Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 257: 1050-1055, 1992.
2. Cohen ML: Antimicrobial resistance: prognosis for public health. Trends Microbiol 2: 422-425, 1994.
3. Clark NM, Hershberger E, Zervosc MJ and Lynch JP: Antimicrobial resistance among gram-positive organisms in the intensive care unit. Infect Dis 9: 403-412, 2003.
4. Sulakvelidze A, Alavidze Z and Morris JG: Bacteriophage therapy. Antimicrob Agents Chemother 45: 649-659, 2001.
5. Kutter E: Phage Therapy: Bacteriophages as Antibiotics. Evergreen State College, Olympia, WA, 1997.
6. Stone R: Stalin's forgotten cure, news focus. Science 298: 728-731, 2002.
7. Travis J: Viruses that slay bacteria draw new interest. Science News 157: 358-360, 2000.
8. Smith HW and Huggins MB: Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 128: 307-318, 1982.
9. Smith HW and Huggins MB: Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs. J Gen Microbiol 129: 2659-2675, 1983.
10. Smith HW, Huggins MB and Shaw KM: Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. J Gen Microbiol 133: 1127-1135, 1987.
11. Smith HW, Huggins MB and Shaw KM: The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol 133: 1111-1126, 1987.
12. Soothill JS: Treatment of experimental infections of mice with bacteriophages. J Med Microbiol 37: 258-261, 1992.
13. Abul-Hassan HS, El-Tahan K, Massoud B and Gomaa R: Bacteriophage therapy of Pseudomonas burn wound sepsis. Ann MBC 3: 1-4, 1990.
14. Soothill JS: Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa. Burns 20: 209-211, 1994.
15. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning: A Laboratory Manual. Vol. 1. 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp66-79, 1989.
16. Biswas B, Adhya S, Washart P, Paul B, Trostel AN, Powell B, Carlton R and Merrill CR: Bacteriophage therapy rescues mice bacteremic from a clinical isolate of Vancomycin-resistant Enterococcus faecium. Infect Immun 70: 204-210, 2002.
17. Adams KH: Bacteriophages. Wiley-Interscience, New York, 1959.
18. Matsuzaki S, Yasuda M, Nishikawa H, Kuroda M, Ujihara T, Shuin T, Shen Y, Jin Z, Fujimoto S, Nasimuzzaman MD, Wakiguchi H, Sugihara S, Sugiura T, Koda S and Muraoka A: Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage ØMR11. J Infect Dis 187: 613-624, 2003.
19. Merril CR, Biswas B, Carlton R, Jensen NC, Creed GJ, Zullo S and Adhya S: Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci USA 93: 3188-3192, 1996.
20. Dean JH, Silva JS and McCoy JL: In vitro human reactivity to staphylococcal phage lysate. J Immunol 115: 1060-1064, 1975.
21. Carlton RM: Phage therapy: past history and future prospects. Arch Immunol Ther Exp 47: 267-274, 1999.
22. Weber-Dabrowska B, Mulczyk M and Gorski A: Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. Transplant Proc 35: 1385-1386, 2003.